1. Field of the Invention
The present invention is directed to a syringe assembly including a space saving plunger cap and plunger rod assembly allowing for reduced storage space and more particularly, to a syringe assembly having a collapsed plunger rod which can be stored alongside a syringe barrel in a pre-use position which can subsequently be expanded and aligned with a stopper assembly into a ready-to-use position.
2. Description of Related Art
Syringe assemblies, and in particular hypodermic syringes, are well known in the medical field for dispensing fluids, such as medication. A conventional syringe typically includes a syringe barrel with an opening at one end and a plunger mechanism disposed through the other end. The plunger typically includes a plunger rod extending through the barrel, with a plunger head or stopper at the end of the plunger rod within the barrel and with a finger flange at the other end of the plunger rod extending out of the barrel. In use, the plunger rod is retracted through the syringe barrel to fill the syringe barrel with a fluid, such as a medication, with the plunger rod extending out from the rear end of the syringe barrel. For delivery of the medication to a patient, the opening of the syringe barrel is adapted for fluid communication with a patient, such as through a hypodermic needle fitted at the front end of the syringe barrel or through a luer-type fitting extending from the front end of the syringe barrel for attachment with a fluid line of a patient. Upon depression of the plunger rod, the plunger rod and stopper travel through the syringe barrel, thereby forcing the contents of the syringe out through the opening at the front end for delivery to the patient. Such an operation is well known in the medical field, and medical practitioners have become well accustomed to the use of such common fluid delivery procedures through standard syringes.
Conventional syringes are well known to be used in connection with a vial of a medication, where the user draws the fluid into the syringe immediately prior to injection and delivery of the fluid to the patient. Oftentimes, hypodermic syringes may be packaged as “pre-filled” devices, wherein the syringe is pre-filled with medication prior to being packaged and delivered to the end user. In this manner, there is no need for the user to fill the device prior to injection, thereby saving time for the end user and maintaining consistent volumes for delivery.
Pre-filled syringes and pre-filled metered dose syringes are often filled with narcotics or other drugs at a production facility, packaged, and then shipped to a medical facility. Once at the facility, these syringes are often placed in controlled storage and/or locked cabinets to reduce theft of the syringes themselves and/or theft of the contents of these syringes. The space within these controlled storage locations is often limited, thus there is a need for a syringe assembly that has a smaller packaging footprint to reduce the storage space required for containing this syringe. It is also desirable to produce syringes that are uniform in terms of an outer surface shape to allow for stacking of the syringes within the storage cabinet.
In accordance with an embodiment of the present invention, a syringe assembly includes a syringe barrel having a first end, a second end, and a sidewall extending between the first and second ends defining a chamber. The syringe assembly also includes a stopper disposed within the chamber of the syringe barrel and a sleeve having a first end and a second end and extending at least partially about the syringe barrel. The syringe assembly further includes a cap associated with the second end of the sleeve, and a plunger rod having a first end and a second end with the first end of the plunger rod associated with the cap. The plunger rod is transitionable from a pre-use position, in which at least a portion of the second end of the plunger rod extends along a portion of the barrel sidewall, and a ready-to-use position in which the plunger rod is aligned with a stopper. Upon proximal movement of the sleeve in a direction away from the first end of the barrel, the plunger rod is configured for lateral movement with respect to the cap into the ready-to-use position.
The syringe assembly may also include a stopper adapter associated with the stopper, and the syringe barrel, stopper, and stopper adapter may be oriented along a longitudinal axis of the syringe assembly. The second end of the plunger rod may include an attachment member configured for cooperation with the stopper adapter. The first end of the plunger rod may include a slideable connection member for engaging a portion of the cap.
In certain configurations, the cap includes a radially extending track for cooperating with the slideable connection member of the plunger rod. In other configurations, the slideable connection member includes one of a male connection member and a female connection member and the track comprises the other of a cooperating male connection member and a cooperating female connection member. In still other configurations, at least a portion of the plunger rod moves along the track upon the application of a lateral force to a portion of the plunger rod.
The sleeve of the syringe assembly may include a distal portion which encompasses a portion of the syringe barrel and may also include at least one leg having a first end associated with the distal portion of the sleeve and a second end associated with the cap. The plunger rod may include a first portion associated with the distal portion of the sleeve and a stop, and a second portion associated with the cap. Upon proximal movement of the sleeve, the stop of the first portion cooperates with a syringe barrel flange to limit the proximal movement of the sleeve with respect to the syringe assembly. In other configurations, the distal portion of the sleeve includes a stop for cooperating with a radially extending flange of the syringe barrel to limit the proximal movement of the sleeve with respect to the syringe assembly.
Optionally, the slideable connection member includes a male connection member and the track includes a female groove extending through the cap for cooperating with the male connection member. At least a top portion of the male connection member may be accessible from a top surface of the cap so that the application of a lateral force to the top portion of the male connection member causes the plunger rod to move along the groove and into contact with the stopper. The syringe assembly may also include a removable dust shield positioned adjacent the top surface of the cap.
The syringe barrel may include an undercut flange portion and the cap may be rotatable about the syringe barrel during assembly to engage the cap with the undercut flange portion to prevent inadvertent actuation. The cap may be rotated about the syringe barrel to disengage the cap from the undercut flange portion prior to movement of the cap in a proximal direction. The syringe assembly may also include a stop member integral with the sleeve to limit proximal movement of the cap with respect to the syringe assembly. Optionally, the syringe assembly may include a liquid within the chamber. The syringe assembly may also include a tamper-indicating label disposed about a portion of the syringe assembly. The syringe assembly may also include a medication or drug disposed within the chamber of the syringe barrel.
In accordance with another embodiment of the present invention, a telescopic plunger rod and cap assembly for use with a syringe assembly includes a sleeve having a first end and a second end and configured for telescopic movement with respect to a syringe barrel. The assembly also includes a cap associated with the second end of the sleeve, and a plunger rod having a first end and a second end, with the first end associated with the cap. The plunger rod is transitionable from a pre-use position, in which at least a portion of the second end of the plunger rod is configured to extend along a portion of the barrel, to a ready-to-use position in which the plunger rod is aligned with a stopper, wherein upon relative movement of the sleeve with respect to the syringe barrel, the plunger rod is configured for lateral movement with respect to the cap into a ready-to-use position.
The second end of the plunger rod may include an attachment member configured for cooperation with the stopper, wherein the first end of the plunger rod includes a slideable connection member. The slideable connection member may include one of a male connection member and a female connection member and a track including the other of a cooperating male connection member and a cooperating female connection member. The sleeve may include a distal portion which encompasses a portion of the syringe barrel and at least one leg having a first end associated with the distal portion of the sleeve and a second end associated with the cap.
The plunger rod may include a first portion associated with the distal portion of the sleeve and including a stop, and a second portion associated with the cap. Upon proximal movement of the sleeve with respect to the syringe barrel, the stop of the first portion cooperates with a syringe barrel flange to limit the proximal movement of the sleeve with respect to the syringe assembly. The distal portion of the sleeve may include a stop surface for cooperating with a syringe barrel flange to limit the proximal movement of the sleeve with respect to the syringe assembly.
In accordance with another embodiment, a syringe assembly includes a syringe barrel having a proximal end, a distal end, and a sidewall extending between the proximal and distal ends defining a chamber. The syringe assembly also includes a stopper disposed within the chamber of the syringe barrel, and a sleeve at least partially disposed about the syringe barrel. The syringe assembly further includes a plunger rod having a first end and a second end, with both the first end and the second end being integral with the sleeve in a first pre-use position and one of the first end and the second end being laterally advanceable with respect to a portion of the sleeve to integrally engage the stopper in a second ready-to-use position.
In certain configurations, the plunger rod moves from the first position to the second position upon proximal movement of the sleeve with respect to the barrel. In other configurations, the plunger rod is movable in a lateral direction with respect to a longitudinal axis of the sleeve upon proximal movement of the sleeve with respect to the barrel. The syringe assembly may also include a stopper adapter associated with the stopper, wherein one of the first end and second end of the plunger rod includes an attachment member configured for cooperation with the stopper adapter when the stopper is in the second position.
For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the invention as it is oriented in the drawing figures. However, it is to be understood that the invention may assume various alternative variations, except where expressly specified to the contrary. It is also to be understood that the specific devices illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the invention. Hence, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered as limiting.
Reference is now made to
With particular reference to
The syringe assembly 10 includes a syringe barrel 12 having a first or distal end 14, a second or proximal end 16, and a sidewall 18 extending between the distal end 14 and proximal end 16 defining an interior chamber 20 of the syringe barrel 12. A stopper 22 is slideably disposed within the chamber 20 of the syringe barrel 12. The syringe barrel 12 may be in the general form of an elongated cylindrical barrel as is known in the art for the general shape of a hypodermic syringe, although other forms for containing a fluid for delivery are also contemplated by the present invention. Additionally, the syringe barrel 12 may be formed of glass, or may be injection molded from thermoplastic material such as polypropylene and polyethylene according to techniques known to those of ordinary skill in the art, though it is to be appreciated that the syringe barrel 12 may be made from other suitable materials and according to other applicable techniques. In certain configurations, the syringe barrel 12 may include an outwardly extending flange 21 about at least a portion of the proximal end 16. The flange 21 may be configured for easy grasping by a medical practitioner, as will be discussed herein.
As illustrated in
The syringe barrel 12 may include markings, such as graduations on the sidewall 18 thereof, for providing an indication as to the level or amount of fluid contained within the syringe barrel 12. Such markings may be provided on the external wall, the internal wall, or integrally formed or otherwise within the wall of syringe barrel 12. Alternatively, or in addition thereto, the markings may provide a description of the contents of the syringe, or other identifying information, as may be known in the art.
As noted, distal end 14 of syringe barrel 12 includes an outlet opening 26. The profile of outlet opening 26 may be adapted for engagement with a separate dispensing device, such as a needle assembly or IV connection assembly, and therefore may include a mechanism for such engagement, for example, a generally tapered luer tip, for engagement with a separate tapered luer mating surface (not shown) of such a separate device for attachment therewith. In addition, a mechanism for locking engagement therebetween may also be provided, such as a luer collar or luer lock including interior threads. Such luer connections and luer locking mechanisms are well known in the art.
All of the components of syringe assembly 10 may be constructed of any known material, and are desirably constructed of medical grade polymers. As stated above, the syringe assembly 10 is particularly useful as a pre-filled syringe, and therefore may be provided for end use with a fluid, such as a medication, contained within interior chamber 20 of syringe barrel 12, pre-filled by the manufacturer. In this manner, syringe assembly 10 can be manufactured, pre-filled with a medication, sterilized, and packaged in appropriate packaging for delivery, storage, and use by the end user, without the need for the end user to fill the syringe with medication from a separate vial prior to use.
With continuing reference to
In order to operate the syringe assembly and to position the plunger rod 36 into a ready-to-use position, reference is made to
The cap 32 can include a thumb press portion 42, or any other type of well-known member, upon which a user can apply a distally directed force DF as shown in
Reference is now made to
As best shown in
With continuing reference to
In accordance with an embodiment of the present invention, the sleeve 30 can include a distal portion 62 which extends at least partially about a portion of the syringe barrel 12 and at least one leg 64 having a first end 66 associated with the distal portion 62 of the sleeve 30 and a second end 68 associated with the cap 32. According to one design, shown in
Reference is now made to
As discussed above, the syringe assembly 10 can be a pre-filled syringe assembly 10. A tamper indicating label 52, as shown in
Reference is now made to
With continuing reference to
Another feature of the present invention is an application flange 182 which is pivotally attached at 183 to the syringe barrel 112 or to the flange 121 of the syringe barrel 112. As shown in
With reference to
It can be appreciated that each of the embodiments disclosed above result in a syringe assembly having a reduced footprint which is desirable in the packaging of the syringe assemblies as it requires less packaging. This reduced footprint provides for syringe assemblies having consistently sized profiles which allow for easy stacking and require less storage space, both of these features being desirable in a controlled storage environment.
While specific embodiments of the invention have been described in detail, it will be appreciated by those skilled in the art that various modifications and alternatives to those details could be developed in light of the overall teachings of the disclosure. Accordingly, the particular arrangements disclosed are meant to be illustrative only and not limiting as to the scope of invention.
This application claims priority to U.S. Provisional Patent Application Ser. No. 61/541,633 filed Sep. 30, 2011, the entire disclosure of which is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1512294 | Marcy | Oct 1924 | A |
1971687 | Kratz | Aug 1934 | A |
2672142 | Melton | Mar 1954 | A |
2672868 | Hickey | Mar 1954 | A |
2871858 | Dann et al. | Feb 1959 | A |
3342319 | Faulseit | Sep 1967 | A |
3353664 | Armentrout et al. | Nov 1967 | A |
3473646 | Burke | Oct 1969 | A |
4011868 | Friend | Mar 1977 | A |
4184593 | Dorr | Jan 1980 | A |
4636202 | Lowin et al. | Jan 1987 | A |
4743234 | Leopoldi et al. | May 1988 | A |
5000744 | Hoffman et al. | Mar 1991 | A |
5176657 | Shields | Jan 1993 | A |
5226884 | Murphy | Jul 1993 | A |
5308330 | Grimard | May 1994 | A |
5344405 | Richards | Sep 1994 | A |
5354285 | Mazurik et al. | Oct 1994 | A |
5407070 | Bascos et al. | Apr 1995 | A |
5411489 | Pagay et al. | May 1995 | A |
5413563 | Basile et al. | May 1995 | A |
5423757 | Olovson et al. | Jun 1995 | A |
5453093 | Haining | Sep 1995 | A |
5478324 | Meyer | Dec 1995 | A |
5558650 | McPhee | Sep 1996 | A |
5573514 | Stiehl et al. | Nov 1996 | A |
5643213 | McPhee | Jul 1997 | A |
5700246 | Stiehl et al. | Dec 1997 | A |
5700247 | Grimard et al. | Dec 1997 | A |
5722951 | Marano | Mar 1998 | A |
5807323 | Kriesel et al. | Sep 1998 | A |
5897532 | Spallek et al. | Apr 1999 | A |
5938642 | Burroughs et al. | Aug 1999 | A |
6001089 | Burroughs et al. | Dec 1999 | A |
6059756 | Yeh | May 2000 | A |
6086568 | Caizza | Jul 2000 | A |
6171286 | Gross | Jan 2001 | B1 |
6228324 | Hasegawa et al. | May 2001 | B1 |
6231550 | Laughlin | May 2001 | B1 |
6338200 | Baxa et al. | Jan 2002 | B1 |
6344031 | Novacek et al. | Feb 2002 | B1 |
6368303 | Caizza | Apr 2002 | B1 |
6485460 | Eakins et al. | Nov 2002 | B2 |
6527751 | Fischer et al. | Mar 2003 | B2 |
6585690 | Hoeck et al. | Jul 2003 | B1 |
6585691 | Vitello | Jul 2003 | B1 |
6599269 | Lewandowski et al. | Jul 2003 | B1 |
6613024 | Gargione | Sep 2003 | B1 |
6622721 | Vedrine et al. | Sep 2003 | B2 |
6676641 | Woodard, Jr. et al. | Jan 2004 | B2 |
6733475 | Huang et al. | May 2004 | B2 |
6866142 | Lamborne et al. | Mar 2005 | B2 |
6878131 | Novacek et al. | Apr 2005 | B2 |
6913592 | Parsons | Jul 2005 | B2 |
7011649 | De La Serna et al. | Mar 2006 | B2 |
7081107 | Kito et al. | Jul 2006 | B2 |
7125394 | Berman et al. | Oct 2006 | B2 |
7141036 | Berman et al. | Nov 2006 | B2 |
7258119 | Mazzoni | Aug 2007 | B2 |
7293803 | Chu | Nov 2007 | B2 |
7361162 | Koller et al. | Apr 2008 | B2 |
7569036 | Domkowski et al. | Aug 2009 | B2 |
7632244 | Buehler et al. | Dec 2009 | B2 |
7645267 | Vetter et al. | Jan 2010 | B2 |
7699052 | Schiewe et al. | Apr 2010 | B2 |
7744580 | Reboul | Jun 2010 | B2 |
7762988 | Vitello | Jul 2010 | B1 |
7828772 | Kriesel et al. | Nov 2010 | B2 |
20030034264 | Hamai et al. | Feb 2003 | A1 |
20050154354 | Kawasaki et al. | Jul 2005 | A1 |
20050192534 | Wolbring et al. | Sep 2005 | A1 |
20060032768 | Hamai et al. | Feb 2006 | A1 |
20070250017 | Carred et al. | Oct 2007 | A1 |
20080114306 | Bare | May 2008 | A1 |
20080202961 | Sharp | Aug 2008 | A1 |
20090318880 | Janish | Dec 2009 | A1 |
20090326479 | Janish et al. | Dec 2009 | A1 |
20110046603 | Felsovalyi et al. | Feb 2011 | A1 |
20110046604 | Felsovalyi et al. | Feb 2011 | A1 |
Number | Date | Country |
---|---|---|
0568207 | Nov 1993 | EP |
0605422 | Jul 1994 | EP |
2085213 | Aug 2009 | EP |
852210 | Feb 1996 | JP |
9173451 | Jul 1997 | JP |
9173452 | Jul 1997 | JP |
10277153 | Oct 1998 | JP |
200014779 | Jan 2000 | JP |
2001104475 | Apr 2001 | JP |
2002172166 | Jun 2002 | JP |
2003260136 | Sep 2003 | JP |
2004329635 | Nov 2004 | JP |
200573985 | Mar 2005 | JP |
2005118238 | May 2005 | JP |
3112395 | Aug 2005 | JP |
2005323849 | Nov 2005 | JP |
2006168767 | Jun 2006 | JP |
2006168768 | Jun 2006 | JP |
2006168769 | Jun 2006 | JP |
200744159 | Feb 2007 | JP |
2007118987 | May 2007 | JP |
2007252828 | Oct 2007 | JP |
2007297065 | Nov 2007 | JP |
200867989 | Mar 2008 | JP |
2008105739 | May 2008 | JP |
2008125803 | Jun 2008 | JP |
2008264256 | Nov 2008 | JP |
3147037 | Dec 2008 | JP |
2008307237 | Dec 2008 | JP |
3149156 | Mar 2009 | JP |
3155666 | Nov 2009 | JP |
2010284438 | Dec 2010 | JP |
201172670 | Apr 2011 | JP |
9218178 | Oct 1992 | WO |
9729798 | Aug 1997 | WO |
9947062 | Sep 1999 | WO |
9962577 | Dec 1999 | WO |
0044422 | Aug 2000 | WO |
0100261 | Jan 2001 | WO |
0141666 | Jun 2001 | WO |
2007015469 | Feb 2007 | WO |
2009061315 | May 2009 | WO |
2009092430 | Jul 2009 | WO |
2009095701 | Aug 2009 | WO |
2010100104 | Sep 2010 | WO |
2010128328 | Nov 2010 | WO |
2010128406 | Nov 2010 | WO |
Number | Date | Country | |
---|---|---|---|
20130085446 A1 | Apr 2013 | US |
Number | Date | Country | |
---|---|---|---|
61541633 | Sep 2011 | US |